Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for GKOS

Stock Name	Glaukos Corp
Ticker	GKOS(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US3773221029
LEI	5299004JA1LHE21M6T14

Show aggregate GKOS holdings

News associated with GKOS

Zacks Research Weighs in on Glaukos’ Q3 Earnings (NYSE:GKOS): Glaukos Corporation (NYSE:GKOS – Free Report) – Investment analysts at Zacks Research lowered their Q3 2026 earnings per share (EPS) estimates for Glaukos in a note issued to investors on Wednesday, August 20th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings per share of $0.02 for the quarter, down […] - 2025-08-25 03:02:49
Vanguard Group Inc. Has $587.09 Million Holdings in Glaukos Corporation (NYSE:GKOS): Vanguard Group Inc. lowered its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 0.2% in the first quarter, Holdings Channel.com reports. The institutional investor owned 5,965,115 shares of the medical instruments supplier’s stock after selling 9,856 shares during the quarter. Vanguard Group Inc. owned approximately 0.10% of Glaukos worth $587,087,000 as of its most […] - 2025-08-14 04:37:10
Natixis Advisors LLC Cuts Stock Position in Glaukos Corporation (NYSE:GKOS): Natixis Advisors LLC lowered its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 12.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,871 shares of the medical instruments supplier’s stock after selling 4,428 shares during the quarter. Natixis […] - 2025-08-07 04:49:06
Thornburg Investment Management Inc. Has $4.96 Million Stake in Glaukos Corporation (NYSE:GKOS): Thornburg Investment Management Inc. increased its stake in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 10.6% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 50,430 shares of the medical instruments supplier’s stock after acquiring an additional 4,847 shares during the period. Thornburg […] - 2025-07-30 04:58:52
KLP Kapitalforvaltning AS Has $1.07 Million Stock Position in Glaukos Corporation (NYSE:GKOS): KLP Kapitalforvaltning AS lessened its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 4.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,900 shares of the medical instruments supplier’s stock after selling 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings […] - 2025-07-29 05:27:00
4,853 Shares in Glaukos Corporation (NYSE:GKOS) Acquired by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd acquired a new position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 4,853 shares of the medical instruments supplier’s stock, valued at approximately $478,000. Several other hedge funds and other institutional investors have also recently bought and sold shares of […] - 2025-07-28 08:10:46
Envestnet Asset Management Inc. Decreases Holdings in Glaukos Corporation (NYSE:GKOS): Envestnet Asset Management Inc. decreased its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 27.8% during the 1st quarter, Holdings Channel.com reports. The fund owned 28,038 shares of the medical instruments supplier’s stock after selling 10,817 shares during the period. Envestnet Asset Management Inc.’s holdings in Glaukos were worth $2,760,000 at the […] - 2025-07-28 04:28:50
Glaukos Corporation (NYSE:GKOS) Shares Acquired by Victory Capital Management Inc.: Victory Capital Management Inc. lifted its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 88.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 140,411 shares of the medical instruments supplier’s stock after buying an additional 66,009 shares during the period. Victory Capital […] - 2025-07-24 05:00:46
4,146 Shares in Glaukos Corporation (NYSE:GKOS) Purchased by OneAscent Financial Services LLC: OneAscent Financial Services LLC bought a new position in Glaukos Corporation (NYSE:GKOS – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,146 shares of the medical instruments supplier’s stock, valued at approximately $408,000. A number of other hedge funds also recently […] - 2025-07-23 06:45:09
Mutual of America Capital Management LLC Sells 324 Shares of Glaukos Corporation (NYSE:GKOS): Mutual of America Capital Management LLC decreased its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 3.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,029 shares of the medical instruments supplier’s stock after selling 324 shares during the period. Mutual of […] - 2025-07-22 07:06:53
Glaukos Corporation (NYSE:GKOS) Shares Acquired by Avior Wealth Management LLC: Avior Wealth Management LLC boosted its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 30.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,384 shares of the medical instruments supplier’s stock after buying an additional 782 shares during the quarter. […] - 2025-06-23 05:51:04
Glaukos Corporation (NYSE:GKOS) Stake Trimmed by Trust Point Inc.: Trust Point Inc. cut its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 53.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,999 shares of the medical instruments supplier’s stock after selling 3,481 shares during the quarter. Trust Point Inc.’s […] - 2025-06-18 05:52:52
Glaukos Corporation (NYSE:GKOS) Receives Consensus Rating of “Moderate Buy” from Analysts: Glaukos Corporation (NYSE:GKOS – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twelve brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have assigned a buy recommendation to the […] - 2025-06-18 02:52:53
Versant Capital Management Inc Purchases 327 Shares of Glaukos Co. (NYSE:GKOS): Versant Capital Management Inc boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 583.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 383 shares of the medical instruments supplier’s stock after acquiring an additional 327 shares during the period. Versant Capital Management Inc’s holdings in Glaukos were worth […] - 2025-06-06 05:44:58
Cetera Investment Advisers Reduces Stock Position in Glaukos Co. (NYSE:GKOS): Cetera Investment Advisers lessened its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 46.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,504 shares of the medical instruments supplier’s stock after selling 1,309 shares during the quarter. Cetera Investment Advisers’ holdings in Glaukos were worth $226,000 as of its most recent SEC […] - 2025-06-02 04:34:59
Royal Bank of Canada Cuts Stake in Glaukos Co. (NYSE:GKOS): Royal Bank of Canada reduced its position in Glaukos Co. (NYSE:GKOS – Free Report) by 41.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 112,310 shares of the medical instruments supplier’s stock after selling 79,841 shares during the quarter. Royal Bank of […] - 2025-05-26 05:27:10
Focus Partners Wealth Invests $379,000 in Glaukos Co. (NYSE:GKOS): Focus Partners Wealth purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 2,528 shares of the medical instruments supplier’s stock, valued at approximately $379,000. Other large investors have also modified their holdings of the company. Rhumbline Advisers raised its stake in […] - 2025-05-22 05:08:53
Analysts See 18% Gains Ahead For USVM: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-20 07:56:36
Glaukos (NYSE:GKOS) Given New $72.00 Price Target at Morgan Stanley: Glaukos (NYSE:GKOS – Get Free Report) had its price objective decreased by stock analysts at Morgan Stanley from $110.00 to $72.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “underweight” rating on the medical instruments supplier’s stock. Morgan Stanley’s price objective suggests a potential downside of 18.40% from the company’s current […] - 2025-05-08 05:00:57
Mariner LLC Sells 783 Shares of Glaukos Co. (NYSE:GKOS): Mariner LLC cut its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 11.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,249 shares of the medical instruments supplier’s stock after selling 783 shares during the period. Mariner […] - 2025-04-28 05:08:52
Barclays PLC Acquires 2,086 Shares of Glaukos Co. (NYSE:GKOS): Barclays PLC lifted its holdings in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,785 shares of the medical instruments supplier’s stock after purchasing an additional 2,086 shares during the quarter. Barclays PLC’s holdings […] - 2025-04-21 05:38:46
Raymond James Financial Inc. Acquires Shares of 112,771 Glaukos Co. (NYSE:GKOS): Raymond James Financial Inc. bought a new position in Glaukos Co. (NYSE:GKOS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 112,771 shares of the medical instruments supplier’s stock, valued at approximately $16,910,000. Several other institutional investors […] - 2025-04-21 04:40:47
Schroder Investment Management Group Acquires 6,991 Shares of Glaukos Co. (NYSE:GKOS): Schroder Investment Management Group grew its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 213.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,259 shares of the medical instruments supplier’s stock after purchasing an additional 6,991 shares during […] - 2025-04-07 05:12:52
Pictet Asset Management Holding SA Purchases 1,041 Shares of Glaukos Co. (NYSE:GKOS): Pictet Asset Management Holding SA lifted its position in Glaukos Co. (NYSE:GKOS – Free Report) by 15.9% in the 4th quarter, Holdings Channel.com reports. The fund owned 7,582 shares of the medical instruments supplier’s stock after acquiring an additional 1,041 shares during the period. Pictet Asset Management Holding SA’s holdings in Glaukos were worth $1,137,000 […] - 2025-04-06 06:25:02
Norges Bank Takes Position in Glaukos Co. (NYSE:GKOS): Norges Bank purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 563,493 shares of the medical instruments supplier’s stock, valued at approximately $84,490,000. A number of other hedge funds […] - 2025-04-03 05:36:55
Glaukos Co. (NYSE:GKOS) Stock Position Lowered by Corebridge Financial Inc.: Corebridge Financial Inc. decreased its position in Glaukos Co. (NYSE:GKOS – Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 26,274 shares of the medical instruments supplier’s stock after selling 2,051 shares during the period. Corebridge Financial Inc.’s holdings in Glaukos were worth […] - 2025-03-31 05:49:01
Congress Wealth Management LLC DE Sells 400 Shares of Glaukos Co. (NYSE:GKOS): Congress Wealth Management LLC DE reduced its stake in Glaukos Co. (NYSE:GKOS – Free Report) by 22.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,389 shares of the medical instruments supplier’s stock after selling 400 shares during the period. […] - 2025-03-31 05:14:58
Glaukos Co. (NYSE:GKOS) Shares Bought by Xponance Inc.: Xponance Inc. boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 13.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,633 shares of the medical instruments supplier’s stock after buying an additional 426 shares during the quarter. Xponance Inc.’s […] - 2025-03-26 05:56:54
Sequoia Financial Advisors LLC Trims Stock Holdings in Glaukos Co. (NYSE:GKOS): Sequoia Financial Advisors LLC lowered its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 6.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,773 shares of the medical instruments supplier’s stock after selling 117 shares during the period. Sequoia Financial Advisors LLC’s holdings in […] - 2025-03-20 06:40:56
Analysts Set Glaukos Co. (NYSE:GKOS) Price Target at $163.25: Glaukos Co. (NYSE:GKOS – Get Free Report) has earned an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-03-13 04:06:47

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc GKOS holdings

Date	Number of GKOS Shares Held	Base Market Value of GKOS Shares	Local Market Value of GKOS Shares	Change in GKOS Shares Held	Change in GKOS Base Value	Current Price per GKOS Share Held	Previous Price per GKOS Share Held
2025-12-16 (Tuesday)	51,156	USD 5,819,507	USD 5,819,507	0	USD 103,847	USD 113.76	USD 111.73
2025-12-15 (Monday)	51,156	USD 5,715,660	USD 5,715,660	0	USD 145,795	USD 111.73	USD 108.88
2025-12-12 (Friday)	51,156	USD 5,569,865	USD 5,569,865	0	USD -17,905	USD 108.88	USD 109.23
2025-12-11 (Thursday)	51,156	USD 5,587,770	USD 5,587,770	0	USD 26,090	USD 109.23	USD 108.72
2025-12-10 (Wednesday)	51,156	USD 5,561,680	USD 5,561,680	0	USD 94,638	USD 108.72	USD 106.87
2025-12-09 (Tuesday)	51,156	USD 5,467,042	USD 5,467,042	0	USD -81,338	USD 106.87	USD 108.46
2025-12-08 (Monday)	51,156	USD 5,548,380	USD 5,548,380	0	USD -2,558	USD 108.46	USD 108.51
2025-12-05 (Friday)	51,156	USD 5,550,938	USD 5,550,938	0	USD -17,393	USD 108.51	USD 108.85
2025-12-04 (Thursday)	51,156	USD 5,568,331	USD 5,568,331	0	USD 71,107	USD 108.85	USD 107.46
2025-12-03 (Wednesday)	51,156	USD 5,497,224	USD 5,497,224	-900	USD -24,356	USD 107.46	USD 106.07
2025-12-02 (Tuesday)	52,056	USD 5,521,580	USD 5,521,580	360	USD 36,117	USD 106.07	USD 106.11
2025-12-01 (Monday)	51,696	USD 5,485,463	USD 5,485,463	0	USD -9,305	USD 106.11	USD 106.29

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GKOS by Blackrock for IE00B3VWM098

Show aggregate share trades of GKOS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-03 SELL -900 109.310 106.030 106.358 USD -95,722 108.23 Profit of 1,688 on sale
2025-12-02 BUY 360 107.825 104.840 105.138 USD 37,850 108.24
2025-11-25 SELL -540 106.040 98.920 99.632 USD -53,801 108.31 Profit of 4,686 on sale
2025-11-24 SELL -540 100.290 96.350 96.744 USD -52,242 108.36 Profit of 6,273 on sale
2025-11-17 SELL -1,980 92.600 88.280 88.712 USD -175,650 108.71 Profit of 39,601 on sale
2025-11-12 BUY 1,051 93.000 89.100 89.490 USD 94,054 108.97
2025-11-06 SELL -176 84.075 81.610 81.857 USD -14,407 109.45 Profit of 4,857 on sale
2025-11-05 SELL -1,760 86.820 83.360 83.706 USD -147,323 109.58 Profit of 45,542 on sale
2025-11-04 SELL -352 88.290 85.160 85.473 USD -30,086 109.71 Profit of 8,530 on sale
2025-11-03 SELL -352 88.670 83.480 83.999 USD -29,568 109.82 Profit of 9,090 on sale
2025-10-28 BUY 528 77.790 77.830 77.826 USD 41,092 110.41
2025-10-24 SELL -176 74.670 76.080 75.939 USD -13,365 110.79 Profit of 6,134 on sale
2025-10-15 BUY 1,056 85.600 86.370 86.293 USD 91,125 111.98
2025-10-02 BUY 176 84.490 85.120 85.057 USD 14,970 112.27
2025-09-30 BUY 352 81.550 81.680 81.667 USD 28,747 112.62
2025-08-21 SELL -168 89.790 90.390 90.330 USD -15,175 113.50 Profit of 3,893 on sale
2025-07-31 BUY 504 86.090 94.810 93.938 USD 47,345 113.81
2025-07-28 SELL -168 94.920 95.475 95.419 USD -16,030 114.17 Profit of 3,149 on sale
2025-06-30 SELL -336 103.290 104.580 104.451 USD -35,096 115.76 Profit of 3,799 on sale
2025-06-25 SELL -168 99.310 101.315 101.115 USD -16,987 116.08 Profit of 2,513 on sale
2025-06-20 SELL -336 100.150 103.120 102.823 USD -34,549 116.44 Profit of 4,575 on sale
2025-05-23 BUY 168 96.020 96.800 96.722 USD 16,249 119.78
2025-05-19 SELL -168 95.850 95.880 95.877 USD -16,107 120.59 Profit of 4,151 on sale
2025-05-16 BUY 1,192 95.470 95.545 95.537 USD 113,881 120.80
2025-05-15 SELL -492 91.620 92.620 92.520 USD -45,520 121.06 Profit of 14,042 on sale
2025-05-12 SELL -164 94.640 96.210 96.053 USD -15,753 121.82 Profit of 4,226 on sale
2025-05-09 SELL -164 89.960 91.830 91.643 USD -15,029 122.11 Profit of 4,997 on sale
2025-04-30 SELL -164 94.250 94.500 94.475 USD -15,494 124.41 Profit of 4,909 on sale
2025-04-24 SELL -328 95.430 95.430 95.430 USD -31,301 125.60 Profit of 9,895 on sale
2025-04-17 SELL -164 90.260 91.430 91.313 USD -14,975 127.48 Profit of 5,931 on sale
2025-04-15 SELL -492 94.520 94.550 94.547 USD -46,517 128.26 Profit of 16,586 on sale
2025-04-14 SELL -492 92.910 93.230 93.198 USD -45,853 128.65 Profit of 17,441 on sale
2025-04-09 SELL -656 93.550 94.460 94.369 USD -61,906 129.93 Profit of 23,327 on sale
2025-04-07 SELL -1,148 86.070 89.930 89.544 USD -102,797 130.99 Profit of 47,582 on sale
2025-04-04 SELL -1,650 83.650 85.470 85.288 USD -140,725 131.55 Profit of 76,330 on sale
2025-03-31 BUY 165 98.420 100.470 100.265 USD 16,544 132.76
2025-03-19 SELL -330 101.240 102.910 102.743 USD -33,905 135.93 Profit of 10,951 on sale
2025-03-14 SELL -990 102.190 103.350 103.234 USD -102,202 137.36 Profit of 33,786 on sale
2025-03-13 SELL -330 96.600 103.275 102.608 USD -33,860 137.94 Profit of 11,661 on sale
2025-03-12 SELL -5,610 103.340 103.940 103.880 USD -582,767 138.44 Profit of 193,908 on sale
2025-03-07 SELL -330 104.190 106.020 105.837 USD -34,926 140.21 Profit of 11,344 on sale
2025-03-06 SELL -495 103.200 110.220 109.518 USD -54,211 140.78 Profit of 15,476 on sale
2025-03-04 BUY 1,002 112.210 113.420 113.299 USD 113,526 141.69
2025-03-03 SELL -163 109.150 120.220 119.113 USD -19,415 142.22 Profit of 3,766 on sale
2025-02-28 SELL -978 120.020 120.190 120.173 USD -117,529 142.58 Profit of 21,913 on sale
2025-02-26 SELL -163 120.490 124.300 123.919 USD -20,199 143.36 Profit of 3,170 on sale
2025-02-25 SELL -489 120.510 125.300 124.821 USD -61,037 143.76 Profit of 9,260 on sale
2025-02-18 BUY 815 152.960 157.330 156.893 USD 127,868 143.72
2025-02-13 BUY 163 146.380 146.765 146.726 USD 23,916 143.28
2025-02-12 BUY 163 143.640 144.695 144.590 USD 23,568 143.28
2025-02-11 BUY 489 145.340 148.995 148.629 USD 72,680 143.23
2025-02-06 BUY 1,458 155.280 156.770 156.621 USD 228,353 142.60
2025-01-30 BUY 779 157.750 161.265 160.913 USD 125,352 140.88
2025-01-27 BUY 160 157.030 161.225 160.806 USD 25,729 139.44
2024-12-30 BUY 800 149.510 151.660 151.445 USD 121,156 137.54
2024-12-06 BUY 640 140.280 142.800 142.548 USD 91,231 137.45
2024-12-05 BUY 160 135.700 137.891 137.672 USD 22,028 137.51
2024-12-04 BUY 800 138.270 140.160 139.971 USD 111,977 137.48
2024-11-29 BUY 800 143.650 144.420 144.343 USD 115,474 137.23
2024-11-27 BUY 640 142.690 144.510 144.328 USD 92,370 136.76
2024-11-26 BUY 160 140.730 144.000 143.673 USD 22,988 136.57
2024-11-25 BUY 8,540 142.940 146.860 146.468 USD 1,250,837 136.27
2024-11-21 BUY 670 140.830 144.140 143.809 USD 96,352 135.62
2024-11-20 BUY 402 141.440 144.495 144.189 USD 57,964 135.30
2024-11-18 BUY 1,608 136.980 139.800 139.518 USD 224,345 134.64
2024-11-12 BUY 1,064 143.630 144.430 144.350 USD 153,588 134.04
2024-11-08 BUY 665 141.750 143.580 143.397 USD 95,359 133.49
2024-11-07 BUY 1,995 139.330 143.240 142.849 USD 284,984 133.04
2024-11-06 BUY 266 140.640 142.450 142.269 USD 37,844 132.41
2024-10-31 BUY 133 132.250 138.288 137.684 USD 18,312 133.20
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-03	SELL	-900	109.310	106.030	106.358	USD -95,722	108.23 Profit of 1,688 on sale
2025-12-02	BUY	360	107.825	104.840	105.138	USD 37,850	108.24
2025-11-25	SELL	-540	106.040	98.920	99.632	USD -53,801	108.31 Profit of 4,686 on sale
2025-11-24	SELL	-540	100.290	96.350	96.744	USD -52,242	108.36 Profit of 6,273 on sale
2025-11-17	SELL	-1,980	92.600	88.280	88.712	USD -175,650	108.71 Profit of 39,601 on sale
2025-11-12	BUY	1,051	93.000	89.100	89.490	USD 94,054	108.97
2025-11-06	SELL	-176	84.075	81.610	81.857	USD -14,407	109.45 Profit of 4,857 on sale
2025-11-05	SELL	-1,760	86.820	83.360	83.706	USD -147,323	109.58 Profit of 45,542 on sale
2025-11-04	SELL	-352	88.290	85.160	85.473	USD -30,086	109.71 Profit of 8,530 on sale
2025-11-03	SELL	-352	88.670	83.480	83.999	USD -29,568	109.82 Profit of 9,090 on sale
2025-10-28	BUY	528	77.790	77.830	77.826	USD 41,092	110.41
2025-10-24	SELL	-176	74.670	76.080	75.939	USD -13,365	110.79 Profit of 6,134 on sale
2025-10-15	BUY	1,056	85.600	86.370	86.293	USD 91,125	111.98
2025-10-02	BUY	176	84.490	85.120	85.057	USD 14,970	112.27
2025-09-30	BUY	352	81.550	81.680	81.667	USD 28,747	112.62
2025-08-21	SELL	-168	89.790	90.390	90.330	USD -15,175	113.50 Profit of 3,893 on sale
2025-07-31	BUY	504	86.090	94.810	93.938	USD 47,345	113.81
2025-07-28	SELL	-168	94.920	95.475	95.419	USD -16,030	114.17 Profit of 3,149 on sale
2025-06-30	SELL	-336	103.290	104.580	104.451	USD -35,096	115.76 Profit of 3,799 on sale
2025-06-25	SELL	-168	99.310	101.315	101.115	USD -16,987	116.08 Profit of 2,513 on sale
2025-06-20	SELL	-336	100.150	103.120	102.823	USD -34,549	116.44 Profit of 4,575 on sale
2025-05-23	BUY	168	96.020	96.800	96.722	USD 16,249	119.78
2025-05-19	SELL	-168	95.850	95.880	95.877	USD -16,107	120.59 Profit of 4,151 on sale
2025-05-16	BUY	1,192	95.470	95.545	95.537	USD 113,881	120.80
2025-05-15	SELL	-492	91.620	92.620	92.520	USD -45,520	121.06 Profit of 14,042 on sale
2025-05-12	SELL	-164	94.640	96.210	96.053	USD -15,753	121.82 Profit of 4,226 on sale
2025-05-09	SELL	-164	89.960	91.830	91.643	USD -15,029	122.11 Profit of 4,997 on sale
2025-04-30	SELL	-164	94.250	94.500	94.475	USD -15,494	124.41 Profit of 4,909 on sale
2025-04-24	SELL	-328	95.430	95.430	95.430	USD -31,301	125.60 Profit of 9,895 on sale
2025-04-17	SELL	-164	90.260	91.430	91.313	USD -14,975	127.48 Profit of 5,931 on sale
2025-04-15	SELL	-492	94.520	94.550	94.547	USD -46,517	128.26 Profit of 16,586 on sale
2025-04-14	SELL	-492	92.910	93.230	93.198	USD -45,853	128.65 Profit of 17,441 on sale
2025-04-09	SELL	-656	93.550	94.460	94.369	USD -61,906	129.93 Profit of 23,327 on sale
2025-04-07	SELL	-1,148	86.070	89.930	89.544	USD -102,797	130.99 Profit of 47,582 on sale
2025-04-04	SELL	-1,650	83.650	85.470	85.288	USD -140,725	131.55 Profit of 76,330 on sale
2025-03-31	BUY	165	98.420	100.470	100.265	USD 16,544	132.76
2025-03-19	SELL	-330	101.240	102.910	102.743	USD -33,905	135.93 Profit of 10,951 on sale
2025-03-14	SELL	-990	102.190	103.350	103.234	USD -102,202	137.36 Profit of 33,786 on sale
2025-03-13	SELL	-330	96.600	103.275	102.608	USD -33,860	137.94 Profit of 11,661 on sale
2025-03-12	SELL	-5,610	103.340	103.940	103.880	USD -582,767	138.44 Profit of 193,908 on sale
2025-03-07	SELL	-330	104.190	106.020	105.837	USD -34,926	140.21 Profit of 11,344 on sale
2025-03-06	SELL	-495	103.200	110.220	109.518	USD -54,211	140.78 Profit of 15,476 on sale
2025-03-04	BUY	1,002	112.210	113.420	113.299	USD 113,526	141.69
2025-03-03	SELL	-163	109.150	120.220	119.113	USD -19,415	142.22 Profit of 3,766 on sale
2025-02-28	SELL	-978	120.020	120.190	120.173	USD -117,529	142.58 Profit of 21,913 on sale
2025-02-26	SELL	-163	120.490	124.300	123.919	USD -20,199	143.36 Profit of 3,170 on sale
2025-02-25	SELL	-489	120.510	125.300	124.821	USD -61,037	143.76 Profit of 9,260 on sale
2025-02-18	BUY	815	152.960	157.330	156.893	USD 127,868	143.72
2025-02-13	BUY	163	146.380	146.765	146.726	USD 23,916	143.28
2025-02-12	BUY	163	143.640	144.695	144.590	USD 23,568	143.28
2025-02-11	BUY	489	145.340	148.995	148.629	USD 72,680	143.23
2025-02-06	BUY	1,458	155.280	156.770	156.621	USD 228,353	142.60
2025-01-30	BUY	779	157.750	161.265	160.913	USD 125,352	140.88
2025-01-27	BUY	160	157.030	161.225	160.806	USD 25,729	139.44
2024-12-30	BUY	800	149.510	151.660	151.445	USD 121,156	137.54
2024-12-06	BUY	640	140.280	142.800	142.548	USD 91,231	137.45
2024-12-05	BUY	160	135.700	137.891	137.672	USD 22,028	137.51
2024-12-04	BUY	800	138.270	140.160	139.971	USD 111,977	137.48
2024-11-29	BUY	800	143.650	144.420	144.343	USD 115,474	137.23
2024-11-27	BUY	640	142.690	144.510	144.328	USD 92,370	136.76
2024-11-26	BUY	160	140.730	144.000	143.673	USD 22,988	136.57
2024-11-25	BUY	8,540	142.940	146.860	146.468	USD 1,250,837	136.27
2024-11-21	BUY	670	140.830	144.140	143.809	USD 96,352	135.62
2024-11-20	BUY	402	141.440	144.495	144.189	USD 57,964	135.30
2024-11-18	BUY	1,608	136.980	139.800	139.518	USD 224,345	134.64
2024-11-12	BUY	1,064	143.630	144.430	144.350	USD 153,588	134.04
2024-11-08	BUY	665	141.750	143.580	143.397	USD 95,359	133.49
2024-11-07	BUY	1,995	139.330	143.240	142.849	USD 284,984	133.04
2024-11-06	BUY	266	140.640	142.450	142.269	USD 37,844	132.41
2024-10-31	BUY	133	132.250	138.288	137.684	USD 18,312	133.20

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GKOS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	155,980	0	408,297	38.2%
2025-09-18	158,440	0	317,147	50.0%
2025-09-17	145,111	0	409,200	35.5%
2025-09-16	140,208	0	407,233	34.4%
2025-09-15	142,351	113	501,810	28.4%
2025-09-12	97,763	1,000	399,810	24.5%
2025-09-11	138,884	0	237,111	58.6%
2025-09-10	124,385	0	380,164	32.7%
2025-09-09	118,497	0	281,646	42.1%
2025-09-08	123,633	0	278,178	44.4%
2025-09-05	153,553	0	305,566	50.3%
2025-09-04	232,653	0	463,856	50.2%
2025-09-03	108,703	0	229,765	47.3%
2025-09-02	81,407	0	157,566	51.7%
2025-08-29	100,573	1,790	186,144	54.0%
2025-08-28	100,902	0	223,292	45.2%
2025-08-27	65,106	0	130,268	50.0%
2025-08-26	54,432	0	202,240	26.9%
2025-08-25	70,980	13	188,332	37.7%
2025-08-22	109,440	0	232,153	47.1%
2025-08-21	60,850	0	97,646	62.3%
2025-08-20	126,239	21	249,995	50.5%
2025-08-19	162,448	0	316,943	51.3%
2025-08-18	87,807	0	204,483	42.9%
2025-08-15	115,279	729	261,975	44.0%
2025-08-14	99,733	0	220,964	45.1%
2025-08-13	169,331	0	418,521	40.5%
2025-08-12	127,458	0	359,205	35.5%
2025-08-11	130,771	0	325,915	40.1%
2025-08-08	88,140	0	336,247	26.2%
2025-08-07	165,915	132	523,296	31.7%
2025-08-06	167,710	0	438,576	38.2%
2025-08-05	194,095	0	592,603	32.8%
2025-08-04	110,453	810	315,314	35.0%
2025-08-01	246,347	2,190	708,244	34.8%
2025-07-31	853,243	1,783	2,112,188	40.4%
2025-07-30	195,473	0	991,119	19.7%
2025-07-29	119,212	299	384,793	31.0%
2025-07-28	98,629	0	352,431	28.0%
2025-07-25	50,782	0	233,956	21.7%
2025-07-24	99,823	0	508,487	19.6%
2025-07-23	55,844	0	348,407	16.0%
2025-07-22	74,546	1,897	413,022	18.0%
2025-07-21	65,768	1,964	210,651	31.2%
2025-07-18	54,629	0	208,520	26.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE